General Information of Drug Off-Target (DOT) (ID: OT6J9UKK)

DOT Name Proline-rich protein 15-like protein (PRR15L)
Synonyms Protein ATAD4
Gene Name PRR15L
Related Disease
Adenocarcinoma ( )
Advanced cancer ( )
UniProt ID
PR15L_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15321
Sequence
MTTEIGWWKLTFLRKKKSTPKVLYEIPDTYAQTEGDAEPPRPDAGGPNSDFNTRLEKIVD
KSTKGKHVKVSNSGRFKEKKKVRATLAENPNLFDDHEEGRSSK

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adenocarcinoma DIS3IHTY Strong Genetic Variation [1]
Advanced cancer DISAT1Z9 Strong Biomarker [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Proline-rich protein 15-like protein (PRR15L). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Proline-rich protein 15-like protein (PRR15L). [10]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Proline-rich protein 15-like protein (PRR15L). [4]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Proline-rich protein 15-like protein (PRR15L). [5]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Proline-rich protein 15-like protein (PRR15L). [6]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Proline-rich protein 15-like protein (PRR15L). [7]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Proline-rich protein 15-like protein (PRR15L). [8]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Proline-rich protein 15-like protein (PRR15L). [9]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Proline-rich protein 15-like protein (PRR15L). [11]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of Proline-rich protein 15-like protein (PRR15L). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Proline-rich protein 15-like protein (PRR15L). [13]
Paraquat DMR8O3X Investigative Paraquat decreases the expression of Proline-rich protein 15-like protein (PRR15L). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 Identification of a novel PRR15L-RSPO2 fusion transcript in a sigmoid colon cancer derived from superficially serrated adenoma.Virchows Arch. 2019 Nov;475(5):659-663. doi: 10.1007/s00428-019-02604-x. Epub 2019 Jun 17.
2 Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.Mol Carcinog. 2009 Jul;48(7):648-61. doi: 10.1002/mc.20511.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
5 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
6 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
7 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
8 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
9 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
12 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
13 Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor . Toxicol Appl Pharmacol. 2020 Jul 15;399:115030. doi: 10.1016/j.taap.2020.115030. Epub 2020 May 6.
14 An in vitro strategy using multiple human induced pluripotent stem cell-derived models to assess the toxicity of chemicals: A case study on paraquat. Toxicol In Vitro. 2022 Jun;81:105333. doi: 10.1016/j.tiv.2022.105333. Epub 2022 Feb 16.